Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia
- 5 October 2001
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 25 (11) , 927-932
- https://doi.org/10.1016/s0145-2126(01)00049-2
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- CD38/CD31, a Receptor/Ligand System Ruling Adhesion and Signaling in Human LeukocytesPublished by S. Karger AG ,2000
- Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.Journal of Clinical Investigation, 1998
- Analysis of somatic mutation in five B cell subsets of human tonsil.The Journal of Experimental Medicine, 1994
- The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoireImmunology Today, 1994
- CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cellsEuropean Journal of Immunology, 1994
- Human CD38: a glycoprotein in search of a functionImmunology Today, 1994
- Formation and Hydrolysis of Cyclic ADP-Ribose Catalyzed by Lymphocyte Antigen CD38Science, 1993
- Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.Journal of Clinical Pathology, 1989
- Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cellsHuman Immunology, 1984
- Total Tumour Mass Score (TTM): a New Parameter in Chronic Lymphocytic LeukaemiaBritish Journal of Haematology, 1981